Triangle Capital Corporation Invests $27.6 Million in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Triangle Capital Corporation Invests $27.6 Million in KidKraft, Inc.

RALEIGH, N.C., Oct. 10, 2016 (GLOBE NEWSWIRE) -- Triangle Capital Corporation (NYSE: TCAP ) (“Triangle” or the “Company”), a leading provider of capital to lower middle market companies, announced today that it closed a $27.6 million second lien debt investment in KidKraft, Inc., a designer and distributor of toys and playsets for children.

About Triangle Capital Corporation

Triangle Capital Corporation ( www.TCAP.com ) invests capital in established companies in the lower middle market to fund growth, changes of control and other corporate events.  Triangle offers a wide variety of investment structures with a primary focus on mezzanine financing with equity components.  Triangle’s investment objective is to seek attractive returns by generating current income from debt investments and capital appreciation from equity related investments.  Triangle’s investment philosophy is to partner with business owners, management teams and financial sponsors to provide flexible financing solutions.  Triangle typically invests $5.0 million - $35.0 million per transaction in companies with annual revenues between $20.0 million and $200.0 million and EBITDA between $3.0 million and $35.0 million.

Triangle has elected to be treated as a business development company under the Investment Company Act of 1940 ("1940 Act").  Triangle is required to comply with a series of regulatory requirements under the 1940 Act as well as applicable NYSE, federal and state laws and regulations.  Triangle has elected to be treated as a regulated investment company under the Internal Revenue Code of 1986.  Failure to comply with any of the laws and regulations that apply to Triangle could have a material adverse effect on Triangle and its stockholders.

Forward Looking Statements

This press release may contain forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Any such statements, other than statements of historical fact, are likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under the Company's control, and that the Company may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance.  Actual developments and results are highly likely to vary materially from these estimates and projections of the future and some of these uncertainties are enumerated in Triangle’s filings with the Securities and Exchange Commission.  Certain factors that could cause actual results to differ materially from those contained in the forward-looking statements are included in our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, each as filed with the Securities and Exchange Commission. Copies are available on the SEC’s website at www.sec.gov and stockholders may receive a hard copy of the completed audited financial statements free of charge upon request to the Company at 3700 Glenwood Avenue, Suite 530, Raleigh, NC 27612. Such statements speak only as of the time when made, and the Company undertakes no obligation to update any such statement now or in the future.

Contacts E. Ashton Poole President & Chief Executive Officer 919-747-8618 apoole@tcap.com Steven C. Lilly Chief Financial Officer 919-719-4789 slilly@tcap.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Pharma Marketing's Systemic Crisis Unveiled by Doceree

Updated Category News Views 35

Complex Inefficiencies Emerge in Pharma Marketing There's a jaw-dropping truth that Doceree just spotlighted about the pharmaceutical marketing game: the industry's been working with blinders on. The findings from their latest survey, "The Broken Command Center," expose a rotting tree in the field of pharma marketing—fragmented systems that limp along like a centipede...

Continue Reading
Boulevard Capital Shines as LendTech Finalist in 2024 Awards

Updated Category News Views 54

Boulevard Capital Recognized in the FinTech Sector Boulevard, the provider of a client experience platform tailored for appointment-based self-care businesses, has recently achieved recognition as a finalist for LendTech of the Year at the prestigious 2024 US FinTech Awards. These awards honor the leading innovators and significant achievements within the rapidly growing...

Continue Reading
Mitchell Partners with PAVE to Enhance Vehicle Inspection Technology

Updated Category News Views 103

Mitchell Enhances Intelligent Solutions with AI Vehicle Inspections Mitchell, a company under Enlyte known for its innovative technology in the property and casualty claims industry, is thrilled to announce a new collaboration with PAVE. This partnership is set to transform and automate vehicle inspections by integrating Mitchell's advanced cloud-based appraisal solutions...

Continue Reading
Oracle Empowers Defense with Tailored Tech

Updated Category News Views 7

Oracle's Strategic Boost for Defense Innovation Today's defense landscape isn't for the faint of heart, and Oracle's stepping up to bat with its Defense Ecosystem initiative. When you're talking about security and military tech, timelines drag longer than they'd like. But boy, Oracle's cutting to the chase—melding tech innovation with real-world application before you...

Continue Reading
Methode Electronics Prepares for Upcoming Quarterly Earnings Call

Updated Category News Views 130

Upcoming Earnings Call for Methode Electronics, Inc. In the ever-evolving world of technology, Methode Electronics, Inc. (NYSE: MEI) stands out as a key player, delivering innovative solutions for user interfaces, lighting systems, and power distribution applications. The company has recently announced its plan to release financial results for the first quarter of fiscal...

Continue Reading